In vitro growth inhibition of mastitis causing bacteria by phenolics and metal chelators.
Antimicrobial activities of three phenolic compounds and four metal chelators were tested at 0, 250, 500, and 1000 ppm in vitro against four major mastitis-causing bacteria, Streptococcus agalactiae, Staphylococcus aureus, Klebsiella pneumoniae, and Escherichia coli. Overall, butylated hydroxyanisole and tert-butylhydroquinone showed the greatest antimicrobial activity. These phenolics were bactericidal at 250 to 500 ppm against all four bacteria tested. The butylated hydroxytoluene was bactericidal against the gram-positive bacteria but was ineffective against the coliforms. At 250 ppm, disodium ethylenediaminetetraacetic acid was bactericidal against the gram-positive bacteria but much less effective against the gram-negatives. However, diethylenetriaminepentaacetic acid was more growth inhibitory than ethylenediaminetetraacetic acid against the gram-negative bacteria and especially against Escherichia coli. All other compounds were generally much less effective or ineffective against all four microorganisms. Therefore, butylated hydroxyanisole, butylated hydroxytoluene, tert-butylhydroquinone, ethylenediaminetetraacetic acid, and diethylenetriaminepentaacetic acid may have practical implications in the prevention or treatment of bovine mastitis.
D000818:Animals; D002083:Butylated Hydroxyanisole / Q000008:administration & dosage / Q000494:pharmacology; D002084:Butylated Hydroxytoluene / Q000008:administration & dosage / Q000494:pharmacology; D002417:Cattle; D002614:Chelating Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003676:Deferoxamine / Q000494:pharmacology; D004492:Edetic Acid / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects*; D005029:Ethylenediamines / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006873:Hydroquinones / Q000008:administration & dosage / Q000494:pharmacology; D066298:In Vitro Techniques; D007711:Klebsiella pneumoniae / Q000187:drug effects*; D008414:Mastitis, Bovine / Q000382:microbiology*; D004369:Pentetic Acid / Q000008:administration & dosage / Q000494:pharmacology; D010636:Phenols / Q000008:administration & dosage / Q000494:pharmacology*; D013211:Staphylococcus aureus / Q000187:drug effects*; D013292:Streptococcus agalactiae / Q000187:drug effects*
D002614:Chelating Agents; D005029:Ethylenediamines; D006873:Hydroquinones; D010636:Phenols; C011813:ethylenediamine-N,N'-bis(2-hydroxyphenylacetic acid); D002084:Butylated Hydroxytoluene; D002083:Butylated Hydroxyanisole; C037740:N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid; D004369:Pentetic Acid; D004492:Edetic Acid; C018855:2-tert-butylhydroquinone; D003676:Deferoxamine